PR Newswire
Danaher Schedules First Quarter 2026 Earnings Conference Call
➖
AI Sentiment
Neutral
5/10
- Home
- DHR
as of 03-24-2026 3:52pm EST
$189.99
$0.01
-0.01%
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
| Founded: | 1969 | Country: | United States |
| Employees: | N/A | City: | WASHINGTON |
| Market Cap: | 166.7B | IPO Year: | 2006 |
| Target Price: | $249.93 | AVG Volume (30 days): | 3.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 15 |
| Dividend Yield: | Dividend Payout Frequency: | N/A | |
| EPS: | 5.05 | EPS Growth: | -4.54 |
| 52 Week Low/High: | $171.00 - $242.80 | Next Earning Date: | 04-21-2026 |
| Revenue: | $19,893,000,000 | Revenue Growth: | 8.53% |
| Revenue Growth (this year): | 5.34% | Revenue Growth (next year): | 6.17% |
| P/E Ratio: | 37.46 | Index: | |
| Free Cash Flow: | 5.3B | FCF Growth: | -0.68% |
Stock Insider Trading Activity of Danaher Corporation (DHR)
Milosevich Gregory M
Sell
Executive Vice President
DHR Feb 19, 2026
Avg Cost/Share
$208.01
Shares
1,320
Total Value
$274,574.52
Owned After
5,099
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Milosevich Gregory M | DHR | Executive Vice President | Feb 19, 2026 | Sell | $208.01 | 1,320 | $274,574.52 | 5,099 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K SELL Jan 28, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K SELLJan 28, 2026 · 100% conf.
AI Prediction SELL
1D
-1.43%
$221.34
Act: -2.19%
5D
-3.11%
$217.57
Act: -2.23%
20D
-1.41%
$221.36
Act: -6.76%
Price: $224.54 Prob +5D: 0% AUC: 1.000
0000313616-26-000004
dhr-20260128False000031361600003136162026-01-282026-01-280000313616us-gaap:CommonStockMember2026-01-282026-01-280000313616dhr:A0.2SeniorNotesDue2026Member2026-01-282026-01-280000313616dhr:A2.1SeniorNotesDue2026Member2026-01-282026-01-280000313616dhr:A1.2SeniorNotesDue2027Member2026-01-282026-01-280000313616dhr:A0.45SeniorNotesDue2028Member2026-01-282026-01-280000313616dhr:A2.5SeniorNotesDue2030Member2026-01-282026-01-280000313616dhr:A0.75SeniorNotesDue2031Member2026-01-282026-01-280000313616dhr:A1.35SeniorNotesDue2039Member2026-01-282026-01-280000313616dhr:A1.8SeniorNotesDue2049Member2026-01-282026-01-28
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 28, 2026
DANAHER CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
Delaware001-0808959-1995548 (State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
2200 Pennsylvania Avenue, N.W., 20037-1701 Suite 800W Washington,DC (Address of Principal Executive Offices) (Zip Code)
202-828-0850 (Registrant’s Telephone Number, Including Area Code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common stock, $0.01 par valueDHRNew York Stock Exchange
0.200% Senior Notes due 2026DHR/26New York Stock Exchange 2.100% Senior Notes due 2026DHR 26New York Stock Exchange 1.200% Senior Notes due 2027DHR/27New York Stock Exchange 0.450% Senior Notes due 2028DHR/28New York Stock Exchange 2.500% Senior Notes due 2030DHR 30New York Stock Exchange 0.750% Senior Notes due 2031DHR/31New York Stock Exchange 1.350% Senior Notes due 2039DHR/39New York Stock Exchange 1.800% Senior Notes due 2049DHR/49New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
ITEM 2.02RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On January 28, 2026, Danaher Corporation (“Danaher”) issued a press release announcing financial results for the year ended December 31, 2025. A copy of the release is furnished herewith as Exhibit 99.1 and incorporated by reference herein. This Current Report on Form 8-K and the press release attached hereto are being furnished by Danaher pursuant to Item 2.02 of Form 8-K. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
ITEM 9.01FINANCIAL STATEMENTS AND EXHIBITS
(c)Exhibits:
Exhibit No. Description
99.1 Press release — “Danaher Reports Fourth Quarter and Full Year 2025 Results”
104 The cover page from this Current Report on Form 8-K, formatted as Inline XBRL.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DANAHER CORPORATION
Date:January 27, 2026By:/s/ Matthew R. McGrew Matthew R. McGrew Executive Vice President and Chief Financial Officer
2025 Q4 Q4 2025 Earnings
8-K SELL Jan 12, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K SELLJan 12, 2026 · 100% conf.
AI Prediction SELL
1D
-1.43%
$221.34
Act: -2.19%
5D
-3.11%
$217.57
Act: -2.23%
20D
-1.41%
$221.36
Act: -6.76%
Price: $224.54 Prob +5D: 0% AUC: 1.000
0000313616-26-000002
dhr-20260112False000031361600003136162026-01-122026-01-120000313616us-gaap:CommonStockMember2026-01-122026-01-120000313616dhr:A0.2SeniorNotesDue2026Member2026-01-122026-01-120000313616dhr:A2.1SeniorNotesDue2026Member2026-01-122026-01-120000313616dhr:A1.2SeniorNotesDue2027Member2026-01-122026-01-120000313616dhr:A0.45SeniorNotesDue2028Member2026-01-122026-01-120000313616dhr:A2.5SeniorNotesDue2030Member2026-01-122026-01-120000313616dhr:A0.75SeniorNotesDue2031Member2026-01-122026-01-120000313616dhr:A1.35SeniorNotesDue2039Member2026-01-122026-01-120000313616dhr:A1.8SeniorNotesDue2049Member2026-01-122026-01-12
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 12, 2026
DANAHER CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
Delaware001-0808959-1995548 (State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
2200 Pennsylvania Avenue, N.W., 20037-1701 Suite 800W Washington,DC (Address of Principal Executive Offices) (Zip Code)
202-828-0850 (Registrant’s Telephone Number, Including Area Code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common stock, $0.01 par valueDHRNew York Stock Exchange
0.200% Senior Notes due 2026DHR/26New York Stock Exchange 2.100% Senior Notes due 2026DHR 26New York Stock Exchange 1.200% Senior Notes due 2027DHR/27New York Stock Exchange 0.450% Senior Notes due 2028DHR/28New York Stock Exchange 2.500% Senior Notes due 2030DHR 30New York Stock Exchange 0.750% Senior Notes due 2031DHR/31New York Stock Exchange 1.350% Senior Notes due 2039DHR/39New York Stock Exchange 1.800% Senior Notes due 2049DHR/49New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
ITEM 2.02RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On January 12, 2026, in advance of a public webcast presentation at the J.P. Morgan Healthcare Conference on January 13, 2026 Danaher Corporation issued a press release regarding the Company’s estimated financial performance for the fourth quarter of 2025 and furnished pursuant to Item 2.02 of Form 8-K such press release as well as the presentation slides attached hereto, each of which is incorporated by reference herein. The presentation slides attached hereto contain certain information regarding Danaher’s estimated financial performance for 2025. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
ITEM 9.01FINANCIAL STATEMENTS AND EXHIBITS
(c)Exhibits:
Exhibit No. Description
99.1 Press release — “Danaher CEO to Comment on Financial Performance”
99.1PRESelected Danaher Presentation Slides for J.P. Morgan Healthcare Conference on January 13, 2026
104 Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DANAHER CORPORATION
Date:January 12, 2026By:/s/ Matthew R. McGrew Matthew R. McGrew Executive Vice President and Chief Financial Officer
2025 Q3 Q3 2025 Earnings
8-K Oct 21, 2025
2025
Q3
Q3 2025 Earnings
8-KOct 21, 2025
0000313616-25-000180
dhr-20251021false000031361600003136162025-10-212025-10-210000313616us-gaap:CommonStockMember2025-10-212025-10-210000313616dhr:A0.2SeniorNotesDue2026Member2025-10-212025-10-210000313616dhr:A2.1SeniorNotesDue2026Member2025-10-212025-10-210000313616dhr:A1.2SeniorNotesDue2027Member2025-10-212025-10-210000313616dhr:A0.45SeniorNotesDue2028Member2025-10-212025-10-210000313616dhr:A2.5SeniorNotesDue2030Member2025-10-212025-10-210000313616dhr:A0.75SeniorNotesDue2031Member2025-10-212025-10-210000313616dhr:A1.35SeniorNotesDue2039Member2025-10-212025-10-210000313616dhr:A1.8SeniorNotesDue2049Member2025-10-212025-10-21
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 21, 2025
DANAHER CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
Delaware001-0808959-1995548 (State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
2200 Pennsylvania Avenue, N.W., 20037-1701 Suite 800W Washington,DC (Address of Principal Executive Offices) (Zip Code)
202-828-0850 (Registrant’s Telephone Number, Including Area Code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common stock, $0.01 par valueDHRNew York Stock Exchange 0.200% Senior Notes due 2026DHR/26New York Stock Exchange 2.100% Senior Notes due 2026DHR 26New York Stock Exchange 1.200% Senior Notes due 2027DHR/27New York Stock Exchange 0.450% Senior Notes due 2028DHR/28New York Stock Exchange 2.500% Senior Notes due 2030DHR 30New York Stock Exchange 0.750% Senior Notes due 2031DHR/31New York Stock Exchange 1.350% Senior Notes due 2039DHR/39New York Stock Exchange 1.800% Senior Notes due 2049DHR/49New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
ITEM 2.02RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On October 21, 2025, Danaher Corporation (“Danaher”) issued a press release announcing financial results for the quarter ended September 26, 2025. A copy of the release is furnished herewith as Exhibit 99.1 and incorporated by reference herein. This Current Report on Form 8-K and the press release attached hereto are being furnished by Danaher pursuant to Item 2.02 of Form 8-K. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
ITEM 9.01FINANCIAL STATEMENTS AND EXHIBITS
(c)Exhibits:
Exhibit No. Description
99.1 Press release — “Danaher Reports Third Quarter 2025 Results”
104 The cover page from this Current Report on Form 8-K, formatted as Inline XBRL.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DANAHER CORPORATION
Date:October 20, 2025By:/s/ Matthew R. McGrew Matthew R. McGrew Executive Vice President and Chief Financial Officer
Latest Danaher Corporation News
DHR Breaking Stock News: Dive into DHR Ticker-Specific Updates for Smart Investing
Insider Monkey
Is Danaher Corporation (DHR) A Good Stock To Buy Now?
📈
AI Sentiment
Highly Positive
8/10
Compare DHR vs Leading Stocks
See how DHR stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "DHR Danaher Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.